Product ID: SQMIG35D2070
Report ID:
SQMIG35D2070 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
92 |
Figures:
76
Orthopedic Surgery in outpatient settings is increasing, favoring the North American Market. North America's market is estimated to rule the industry for the entire forecast year. The market in North America may see growth between 2019 and 2026 as a result of the business strategies of top American manufacturers, benevolent reimbursement policies, rising prevalence of degenerative bone diseases, and rising trend of orthopaedic procedures in outpatient settings. Due to the recent marketing approval for Cingal, a viscosupplement, in Europe, Europe is anticipated to be the second most lucrative region with a sizable market share..
Due to the rising demand for viscosupplements in India and the growing number of independent orthopaedic clinics, Asia Pacific is anticipated to have the highest CAGR throughout the projection period. Due to the increased need for the treatment of sports injuries and a rise in government initiatives to raise awareness of orthobiologics, Latin America and the Middle East & Africa are anticipated to have a significant market potential during the projection period.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONOrthobiologics Market size was valued at USD 7.63 billion in 2019 and is poised to grow from USD 8.56 billion in 2023 to USD 12.33 billion by 2031, growing at a CAGR of 5.4% in the forecast period (2024-2031).
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQMIG35D2070